A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia

Clinical trial NCT07345000 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07345000
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Treatment-naïve Severe Aplastic Anemia

Start date: 2026-01-01
Primary completion: 2029-10-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.